Vanessa C. Haubensak
Dr. iur., Attorney at Law

Vanessa C. Haubensak Vanessa C. Haubensak Vanessa C. Haubensak Vanessa C. Haubensak


Vanessa Haubensak is an Attorney at Law in the Basel office of Walder Wyss. Her main areas of practice include corporate and commercial law, real property law, marriage and inheritance law as well as the freezing of assets and the enforcement of judgments. Vanessa Haubensak advises in contentious as well as non-contentious matters and represents parties before courts.

Born in 1987, Vanessa Haubensak was educated at the University of Basel (BLaw 2009, MLaw 2011, Dr. iur. 2017). Vanessa Haubensak was admitted to the bar in 2013, after having worked as a trainee lawyer at a leading law firm in Basel and at the Civil Court of Basel-City. Before joining Walder Wyss, Vanessa Haubensak gained working experience as a notary trainee at the Land Registry and the Commercial Registry Basel-City. Thereafter, Vanessa Haubensak worked as a research and teaching assistant for civil law and for civil procedure law at the law faculty of the University of Basel.

Vanessa Haubensak's prodessional languages are German and English. She is registered with the bar registry of the canton of Basel-Stadt and admitted to practice in all Switzerland.

Contact
Vanessa C. Haubensak
Direct phone: +41 58 658 14 99


Walder Wyss Ltd.
Aeschenvorstadt 48
P.O. Box 633
4010 Basel
Switzerland
Phone +41 58 658 10 00
Fax +41 58 658 59 59
vCard


Practice Areas

Vanessa C. Haubensak Vanessa C. Haubensak Vanessa C. Haubensak Vanessa C. Haubensak

Vanessa C. Haubensak
Dr. iur., Attorney at Law

Vanessa Haubensak is an Attorney at Law in the Basel office of Walder Wyss. Her main areas of practice include corporate and commercial law, real property law, marriage and inheritance law as well as the freezing of assets and the enforcement of judgments. Vanessa Haubensak advises in contentious as well as non-contentious matters and represents parties before courts.

Born in 1987, Vanessa Haubensak was educated at the University of Basel (BLaw 2009, MLaw 2011, Dr. iur. 2017). Vanessa Haubensak was admitted to the bar in 2013, after having worked as a trainee lawyer at a leading law firm in Basel and at the Civil Court of Basel-City. Before joining Walder Wyss, Vanessa Haubensak gained working experience as a notary trainee at the Land Registry and the Commercial Registry Basel-City. Thereafter, Vanessa Haubensak worked as a research and teaching assistant for civil law and for civil procedure law at the law faculty of the University of Basel.

Vanessa Haubensak's prodessional languages are German and English. She is registered with the bar registry of the canton of Basel-Stadt and admitted to practice in all Switzerland.

Vanessa C. Haubensak
Direct phone: +41 58 658 14 99

Walder Wyss Ltd.
Aeschenvorstadt 48
P.O. Box 633
4010 Basel
Switzerland
Phone +41 58 658 10 00
Fax +41 58 658 59 59


vCard

Practice Areas

No publication found with your search criteria.


Deals and Cases

Precision Surfacing Solutions acquires Meyer Burger's wafering business

Precision Surfacing Solutions (PSS) (formerly Lapmaster Wolters Ltd), a global supplier of equipment and services for surface enhancement technology, intends to acquire from Meyer Burger Technology Ltd (SIX Swiss Exchange: MBTN) the wafering business consisting of photovoltaic and specialised materials (e.g. semiconductor and sapphire glass industries) wafering equipment and service business. As part of the transaction, significant parts of Meyer Burger's current production facilities in Thun as well as around 100 employees involved in the wafering technology portfolio in Thun and the relevant service locations worldwide will also be transferred to PSS. Completion of the contract is subject to standard closing conditions. The closing of the transaction is expected to be completed towards the end of the first quarter of 2019. The agreed purchase price is CHF 50 million plus earn-out component. Both Meyer Burger and PSS view the transaction as an important strategic milestone, which will further strengthen two global technology leaders. 

PSS is a recognized industry leader in the development of technology to produce micron accuracy surface finishes. PSS is headquartered in Mt. Prospect, IL/USA, employing over 900 people across 13 manufacturing facilities on three continents. 

Walder Wyss has advised PSS on this transaction. The Walder Wyss team was led by Robert von Rosen (Partner, Corporate/M&A) and included Alexander Gutmans (Partner, Corporate/M&A), Thomas P. Müller (Partner, Real Estate), Markus R. Frick (Partner, IP/IT), Fabian Looser (Managing Associate, Employment), Vanessa C. Haubensak (Associate, Corporate), Christoph Zogg (Associate, Litigation) und Flora Stanischewski (Associate, Commercial).


Cellestia Biotech AG: CHF 20 million Series A financing round

Walder Wyss advises FC Capital Fund I, L.P., Shanghai, as investor in connection with Cellestia's recent financing round. Cellestia was founded in 2014 as a spin-off from EPFL (Ecole Polytechnique Fédérale de Lausanne). Its pipeline including lead candidate, oral small molecule CB-103 is based on proprietary know-how and more than two decades of research at Swiss Institute for Experimental Cancer Research (ISREC) at EPFL.

The Walder Wyss team included Alexander Gutmans (Partner, Corporate, Venture Capital), Stefano Codoni (Partner, IP Life Sciences), Robert von Rosen (Partner, Corporate M&A), Jessica Aeschbach Flórez (Associate, Corporate) as well as Vanessa C. Haubensak (Associate, Corporate).


Swiss Auris Medical Holding AG (Nasdaq) implements Reverse Share Split through Intra-Group Merger

On March 12, 2018, the extraordinary general meeting of shareholders approved the merger of Auris Medical Holding AG, a Swiss company listed on Nasdaq, into Auris Medical NewCo Holding AG, a newly incorporated, wholly-owned Swiss Subsidiary. The Merger became effective on March 13, 2018, upon its registration in the Commercial Register in the Canton of Zug, Switzerland. Pursuant to the Merger, the shareholders of the transferring entity received 1 registered share with a nominal value of CHF 0.02 of the surviving company for every 10 old registered shares with a nominal value of CHF 0.40 each, effectively resulting in a “reverse share split” at a ratio of 10-for-1. The registered shares of the surviving company (renamed Auris Medical Holding AG) start trading on the Nasdaq Capital Market on March 14, 2018, under the trading symbol “EARS”. 

Walder Wyss has acted as legal counsel to Auris Medical. The team has been led by Alex Nikitine (Partner, M&A, Capital Markets) and further included Thiemo Sturny (Counsel, M&A, Capital Markets), Marion Bähler (Associate, M&A, Capital Markets), Vanessa C. Haubensak (Associate, M&A, Notary Services), Janine Corti (Counsel, Tax) and Michael Müller (Trainee, Corporate/M&A).


BC Platforms CHF 10 Mio. B Round

Walder Wyss advises BC Platforms AG, Basel, on its Series B financing Round. The financing round amounts to CHF 10 mio. was subscribed by Debiopharm Innovation Fund and Finnish Industry Investment as lead investors as well as by existing shareholders.

The Walder Wyss teams consisted of Alexander Gutmans (Partner, Corporate Venture Capital, Life Sciences), Robert von Rosen (Partner, Corporate) and Vanessa C. Haubensak (Associate, Corporate).


Curriculum Vitae PDF